References

Allard B, et al. Semin Cancer Biol. 2018;doi:10.1016/j.semcancer.2018.02.005.

Boussiotis VA, et al. Cancer J. 2014;doi:10.1097/PPO.0000000000000059.

Butte MJ, et al. Immunity. 2007;doi:10.1016/j.immuni.2007.05.016.

Cerezo-Wallis D, Soengas MS. Curr Pharm Des. 2016;doi:10.2174/1381612822666160826111041.

Chambers BJ, et al. Immunity. 1996;doi:10.1016/s1074-7613(00)80257-5.

Crotta S, et al. J Exp Med. 2002;doi:10.1084/jem.20011124.

Dong H, et al. Nat Med. 1999;doi:10.1038/70932.

Draghi A, et al. Acquired resistance to cancer immunotherapy. Semin Immunopathol. 2019;41(1):31-40.

Ghiotto M, et al. Int Immunol. 2010;doi:10.1093/intimm/dxq049.

Goronzy JJ, Weyand CM. Arthritis Res Ther. 2008;doi:10.1186/ar2414.

Hui E, et al. Science. 2017;doi:10.1126/science.aaf1292.

Kwon B. Immune Netw. 2009;doi:10.4110/in.2009.9.3.84.

Larsen TV, et al. Cancer Commun (Lond). 2019;doi:10.1186/s40880-019-0376-6.

Pauken KE, Wherry EJ. Trends Immunol. 2015;doi:10.1016/j.it.2015.02.008.

Ramsay AG. Br J Haematol. 2013;doi:10.1111/bjh.12380.

Sharma P, Allison JP. Science. 2015;doi:10.1126/science.aaa8172.

Tsushima F, et al. Blood. 2007;doi:10.1182/blood-2006-11-060087.

Wei SC, et al. Cancer Discov. 2018;doi:10.1158/2159-8290.CD-18-0367.

Wykes MN, Lewin SR. Nat Rev Immunol. 2018;doi:10.1038/nri.2017.112.

Thank you for participating in this module. Click below to download the certificate.